Subject search results

1 Document(s) [ Subject: Rebates ]

Committee: House Insurance
Title: Interim Report
Subjects: Consumer protection | Emergency medical services | Health insurance | Insurance industry | Prescription drug costs | Prescription drugs | Rebates | Texas Mutual Insurance |
Library Call Number:
Session: 87th R.S. (2021)
Online version: View report [113 pages  File size: 2,704 kb]
Charges: This report should address the charges below.
1. Monitor the agencies and programs under the Committee’s jurisdiction and oversee the implementation of relevant legislation passed by the 87th Legislature. Conduct active oversight of all associated rulemaking and other governmental actions taken to ensure the intended legislative outcome of all legislation, including the following:
  • HB 18, 87th R.S., relating to the establishment of the prescription drug savings program for certain uninsured individuals;
  • HB 3459, 87th R.S., relating to preauthorization requirements for certain health care services and utilization review for certain health benefit plans;
  • HB 3752, 87th R.S., relating to the offering of health benefit coverage by subsidiaries of the Texas Mutual Insurance Company; and
  • HB 3924, 87th R.S., relating to health benefits offered by certain nonprofit agricultural organizations.
2. Review existing state laws, administrative regulations, and agency practices to identify barriers to competition in the insurance marketplace. Examine existing business practices in the industry to determine if additional laws or regulations are needed to promote competition, lower premiums, and protect consumers.
3. Monitor the implementation, compliance, and enforcement of legislation related to freestanding emergency rooms to determine whether patients are adequately protected and if further safeguards and disclosures are needed.
4. Review Texas' insurance anti-rebating laws and model legislation related to rebates. Make recommendations for legislation that would preserve the purpose of the current statute while allowing certain services for and benefits to insurance consumers.
5. Study the impacts of the U.S. Supreme Court’s 2020 decision in Rutledge v. Pharmaceutical Care Management Association and the federal No Surprises Act (2021 Consolidated Appropriations Act, Public Law No. 116-620) on the Texas insurance market.

Information on this website is provided as a public service by the Legislative Reference Library. The Legislative Reference Library makes no representation as to its completeness or accuracy and makes no warranty in regard to its use. Users assume all risk of reliance on the information included on this site.